1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
Novel Drug Delivery Systems (NDDS) Market - Growth, Trends, and Forecast (2020 - 2025)

Novel Drug Delivery Systems (NDDS) Market - Growth, Trends, and Forecast (2020 - 2025)

  • January 2021
  • 124 pages
  • ID: 6009449
  • Format: PDF
  • Mordor Intelligence LLP
Up to $750 off Until Mar 10th 2021


Table of Contents

Search Inside

The major factors for the growth of the novel drug delivery systems (NDDS) market include the growing need of controlled release of drugs, advancement in pharmacology promoting increased adoption of novel drug delivery systems (NDDS), and technological advancements promoting the development of NDDS.

There has been a remarkable increase in the adoption of controlled release drug delivery systems owing to various factors such as the prohibitive cost of developing new drug entities, expiration of existing international patents, the discovery of new polymeric materials suitable for prolonging the drug release, and the improvement in therapeutic efficiency. The adoption of controlled release systems has grown over the past decade rapidly, and the growth rate is expected to sustain during the forecast period.

The increasing adoption of various controlled release drugs, increasing demand for and awareness about advanced products amongst physicians, and growing prescription trends for controlled release products are propelling the growth of the NDDS market. There are many improvements made in delivery techniques which can minimize the toxicity and improve the efficacy, to offer great potential benefits to the patients helping to open up new markets for pharmaceutical and drug delivery companies.

Key Market Trends
Oral Drug Delivery Systems is the Segment under Route of Administration is expected to be Fastest Growing Market over the Forecast Period

Oral drug delivery has found to be the most preferred and convenient route of drug administration, due to high patient compliance, cost-effectiveness, least sterility constraints, flexibility in the design of dosage form, and ease of production. The oral route is found to be the most popular and successful route for controlled delivery of drugs because of its flexibility in the designing of dosage form than other routes. The immediate release of conventional dosage form lack in the efficiency of controlling the proper plasma drug concentration. This factor as well as factors, such as repetitive dosing and unpredictable absorption help in driving the oral controlled release drug delivery systems. In oral administration, drugs should be protected under unstable biological environments, including drug degradation induced by the GI tract and first-pass liver effects after oral administration before reaching the targeted sites. There are different mechanistic aspects for design of oral controlled release drug delivery systems, such as matrix, reservoir, osmotic pressure, ion exchange resins, altered density, etc. The oral drug delivery is majorly driven by the increasing incidence of chronic diseases, improving patient compliance, reformulation and repositioning of drugs using advanced oral delivery systems, and huge investments made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.

North America is expected to account for Largest Market Share in the Global Market

North America is expected to be the largest market owing to the presence of better healthcare infrastructure and rising prevalence of various chronic diseases. Cardiovascular disease (CVD) is the leading cause of death and a major cause of disability worldwide. According to the American Heart Association, 2017 reports that cardiovascular disease (CVD) accounts for approximately 800,000 deaths in the United States (US), or one out of every three deaths. On a global level, CVD accounts for 31% of all deaths. The estimated cost of CVD will be USD 1,044 billion by 2030. African–Americans are more prone to these diseases; nearly 48% of women and 46% of men have some form of cardiovascular disease. The report estimates that the direct and indirect costs (along with lost productivity due to cardiovascular diseases and stroke) are over USD 400 billion, annually. Pharmaceutical drugs have to be used efficiently due to the associated high costs and reducing healthcare spending; novel drug delivery systems can help in using drugs more efficiently. Targeted delivery systems, which can specifically target a diseased part of the body, can help treat some diseases that require low amounts of the drug. Also, they can also eliminate side-effects associated with excessive drug use or drugs accumulated at the wrong site, thus, decreasing the overall cost associated with the procedure. According to Pharmaceutical Research and Manufacturers of America (PhRMA), the members of PhRMA have invested USD 51.2 billion in 2014 in R&D of novel medicines. Also, FDA approvals for commercial availability of NDDS and rise in the number of clinical trials for this therapy are expected to boost the market growth in this region.

Competitive Landscape
The market studied is consolidated market owing to the presence of major market players. The market players are focusing on the development of innovative treatment options in order to grab maximum market share. Some of the market players are Abbott Laboratories, AstraZeneca PLC, Bayer AG, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer Inc., and Sanofi SA

Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
10% Off


  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Middle East and Africa Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product ; Technology ; Application, and Country

  • $ 3000
  • November 2020
  • 125 pages

Market Introduction The Liposome are novel drug delivery system (NDDS), they are vesicular structures consisting of bilayers which form spontaneously when phospholipids are disappeared in water. They are ...

  • Middle East
  • Africa
  • Drug Delivery
  • Industry analysis
  • Chronic Disease Prevalence
  • Mortality Rate


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on